Hospitals, clinics, and home health services lead hiring, offsetting weaker gains in other industries.

Participants who engage with financial guidance resources contribute 29% more on average and hold roughly twice the account balance of non-users.

This accounts for roughly one-third of national health expenditures in 2024 and driving costs for families, employers, Medicare, Medicaid and other payers.

The company said its 27,000 pharmacists will guide customers in applying the discounts and support related programs, including NovoCare enrollment and reduced pricing on fertility medications through the TrumpRx Fertility initiative.

Medical inflation is projected at nearly 6% annually, outpacing income growth and pushing lifetime health care costs toward $1 million for many couples.

EBSA said the $1.4 billion returned to plans, participants and beneficiaries represents a slight increase from the $1.384 billion recovered in fiscal year 2024.

Demand for obesity and metabolic therapies is accelerating deal activity as pharma companies shift from blockbuster drugs to platform control.

Global prevalence climbs, boosting demand for insulin, devices and new therapies like Mounjaro and Ozempic.